Coverage at a glance
| Indication | Coverage |
|---|---|
| Obesity / chronic weight management | Not covered |
| Type 2 diabetes (GLP-1 class, covered pathway) | Covered with prior authorization |
Plan type: Commercial fully insured and HMO (BlueChoice, BlueOptions, BlueSelect, BlueCare, myBlue, SimplyBlue, Truli for Health).
This varies by plan. The exclusion in this bulletin applies to Florida Blue's listed fully insured commercial plans (BlueChoice, BlueOptions, BlueSelect, BlueCare, myBlue, SimplyBlue, and Truli for Health). Self-funded employer groups administered by Florida Blue set their own pharmacy benefit, so a minority add anti-obesity coverage as a buy-up. Confirm your specific plan before assuming the drug is excluded. The pharmacy benefit manager is Prime Therapeutics, and prior-authorization requests route through CoverMyMeds. Florida Blue Medicare Advantage follows CMS rules, so pure obesity is not covered there either.
If the weight-loss exclusion above applies to you, you are paying for this yourself.
Coverage by indication
| BMI threshold | Not applicable. Weight-management drugs are excluded regardless of BMI. |
What the prior authorization needs:
- Wegovy, Zepbound, and Saxenda are named as excluded from coverage under Florida Blue's health insurance plans
- A prior-authorization request submitted for a weight-loss or weight-management indication will be denied and the patient pays out of pocket
- Effective April 1, 2025, members on a prescribed GLP-1 therapy must have a prior authorization on file, and only type 2 diabetes qualifies
Policy Provider bulletin 119973 0125 (January 2025). Source: Florida Blue (GuideWell) provider bulletin, GLP-1 Prior Authorization Requirement for Commercial Plans, effective April 1, 2025. Official payer bulletin PDF fetched from GuideWell (Florida Blue's corporate document host); the two-page PDF was read in full and the exclusion language is quoted verbatim. Verified August 18, 2026.
| BMI threshold | Not applicable to the diabetes pathway. |
| Step therapy | The patient must have tried and failed metformin, a metformin combination drug, or insulin. |
What the prior authorization needs:
- Clinical documentation of a type 2 diabetes diagnosis at submission
- Records showing metformin, metformin combination drugs, or insulin was tried and failed
- Prior authorization required as of April 1, 2025
- Preferred covered GLP-1 drugs for type 2 diabetes are Mounjaro, Ozempic, Rybelsus, and Trulicity
- Requests are reviewed by Prime Therapeutics and submitted through CoverMyMeds; criteria questions are at myPrime.com
Policy Provider bulletin 119973 0125 (January 2025). Source: Florida Blue (GuideWell) provider bulletin, GLP-1 Prior Authorization Requirement for Commercial Plans, effective April 1, 2025. Official payer bulletin PDF fetched from GuideWell (Florida Blue's corporate document host); the two-page PDF was read in full and the covered-drug list is quoted verbatim. Verified August 18, 2026.
What to do next
If you qualify under one of the covered indications above, prior authorization is the path. Match the documentation in the requirements list then have your prescriber submit it. Plans that approve reassess at renewal, so know your long-term maintenance dose before you start.
- Browse the prior-authorization letter library for a template that matches your plan and indication.
- Read the full coverage picture, denial reasons, and the four appeal pathways at GLP-1 insurance coverage.
- If the prior-authorization request is denied, the appeal letter library has templates by denial reason, covering peer-to-peer review, Level 1 and Level 2 internal appeal, and external review.
- Call the number on your insurance card and ask whether your specific plan includes the weight-management drug benefit before you submit.
- If your plan does not cover the indication you need, compare cash prices in the cost guide or check whether a clinical trial near you fits. Neither one goes through your insurer. Clinical trials cost nothing and many pay you for your time. Some participants get a placebo, decided at random.
What it costs without insurance
The programs below bill you directly.
Some visit links earn us a commission. Disclosure
Frequently asked questions
Does Florida Blue cover Wegovy and Zepbound for weight loss?
No. Florida Blue commercial plans exclude Wegovy, Zepbound, and Saxenda for weight loss and cover GLP-1 drugs only for type 2 diabetes, per its provider bulletin effective April 1, 2025. This reflects the published policy verified August 2026.
What does Florida Blue require to approve Wegovy and Zepbound for weight loss?
For type 2 diabetes (GLP-1 class, covered pathway): The BMI requirement is not applicable to the diabetes pathway.. The patient must have tried and failed metformin, a metformin combination drug, or insulin.
Why might Florida Blue deny Wegovy and Zepbound for weight loss even if I meet the criteria?
The exclusion in this bulletin applies to Florida Blue's listed fully insured commercial plans (BlueChoice, BlueOptions, BlueSelect, BlueCare, myBlue, SimplyBlue, and Truli for Health). Self-funded employer groups administered by Florida Blue set their own pharmacy benefit, so a minority add anti-obesity coverage as a buy-up. Confirm your specific plan before assuming the drug is excluded. The pharmacy benefit manager is Prime Therapeutics, and prior-authorization requests route through CoverMyMeds. Florida Blue Medicare Advantage follows CMS rules, so pure obesity is not covered there either.
Coverage for other payers
See the full payer coverage index for every plan we have sourced.
How we built this page
Each page is built from a published payer policy document, government statute, or independent formulary analysis (KFF). Every indication row carries the source URL and the date we verified it. Where a payer's policy PDF was confirmed at its public URL but served as an unreadable binary, the policy number and coverage framework were cross-checked against secondary sources; those rows are marked lower confidence. Commercial coverage often depends on whether an employer elected the weight-management benefit. Those rows say varies by plan rather than a flat yes.
This is reference information, not medical or legal advice, and not a guarantee of coverage. GLP-1 coverage policies change often. Always confirm the current policy with your insurer using the number on your card before you rely on this page. If your experience differs from what is shown here, email hello@glpchart.com with the details and we will re-verify.
